WallStreetZenWallStreetZen

NASDAQ: TMDX
Transmedics Group Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for TMDX

Based on 7 analysts offering 12 month price targets for Transmedics Group Inc

Min Forecast
$115.00-9.92%
Avg Forecast
$143.43+12.34%
Max Forecast
$166.00+30.02%

Should I buy or sell TMDX stock?

Based on 7 analysts offering ratings for Transmedics Group Inc.

Buy
Strong Buy
3 analysts 42.86%
Buy
2 analysts 28.57%
Hold
2 analysts 28.57%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although TMDX's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates TMDX as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their TMDX stock forecasts and price targets.

TMDX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-17
lockedlocked$00.00+00.00%2025-12-08
lockedlocked$00.00+00.00%2025-12-02
lockedlocked$00.00+00.00%2025-10-30
lockedlocked$00.00+00.00%2025-10-13
Evercore ISI Group
Top 29%
72
BuyInitiates Coverage On$155.00+21.41%2025-09-16
Stifel Nicolaus
Top 20%
81
HoldInitiates Coverage On$115.00-9.92%2025-09-04

1 of 1

Forecast return on equity

Is TMDX forecast to generate an efficient return?

Company
42.39%
Industry
28.35%
Market
227.93%
TMDX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is TMDX forecast to generate an efficient return on assets?

Company
15.92%
Industry
13.34%
TMDX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TMDX earnings per share forecast

What is TMDX's earnings per share in the next 3 years based on estimates from 16 analysts?

Avg 1 year Forecast
$2.66-1.73%
Avg 2 year Forecast
$2.95+9.03%
Avg 3 year Forecast
$3.64+34.4%
TMDX's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

TMDX revenue forecast

What is TMDX's revenue in the next 3 years based on estimates from 16 analysts?

Avg 1 year Forecast
$612.9M+8.22%
Avg 2 year Forecast
$738.5M+30.39%
Avg 3 year Forecast
$868.6M+53.36%
TMDX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TMDX earnings growth forecast

How is TMDX forecast to perform vs Medical Devices companies and vs the US market?

Company
9.61%
Industry
14.2%
Market
42.43%
TMDX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
TMDX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
TMDX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

TMDX revenue growth forecast

How is TMDX forecast to perform vs Medical Devices companies and vs the US market?

Company
15.28%
Industry
7.11%
Market
25.68%
TMDX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TMDX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TMDX vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
TMDX$127.67$143.43+12.34%Buy
LIVN$62.82$69.00+9.84%Buy
IRTC$174.17$211.15+21.23%Strong Buy
ATEC$20.01$22.40+11.94%Strong Buy
INSP$96.54$136.31+41.20%Buy
View Top Medical Device Stocks

Transmedics Group Stock Forecast FAQ

Is Transmedics Group Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: TMDX) stock is to Buy TMDX stock.

Out of 7 analysts, 3 (42.86%) are recommending TMDX as a Strong Buy, 2 (28.57%) are recommending TMDX as a Buy, 2 (28.57%) are recommending TMDX as a Hold, 0 (0%) are recommending TMDX as a Sell, and 0 (0%) are recommending TMDX as a Strong Sell.

If you're new to stock investing, here's how to buy Transmedics Group stock.

What is TMDX's earnings growth forecast for 2025-2027?

(NASDAQ: TMDX) Transmedics Group's forecast annual earnings growth rate of 9.61% is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 14.2%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.43%.

Transmedics Group's earnings in 2025 is $91,765,000.On average, 16 Wall Street analysts forecast TMDX's earnings for 2025 to be $91,006,227, with the lowest TMDX earnings forecast at $81,717,646, and the highest TMDX earnings forecast at $104,060,820. On average, 16 Wall Street analysts forecast TMDX's earnings for 2026 to be $100,971,461, with the lowest TMDX earnings forecast at $66,646,769, and the highest TMDX earnings forecast at $133,484,913.

In 2027, TMDX is forecast to generate $124,473,144 in earnings, with the lowest earnings forecast at $79,038,379 and the highest earnings forecast at $183,721,171.

What is TMDX's revenue growth forecast for 2025-2027?

(NASDAQ: TMDX) Transmedics Group's forecast annual revenue growth rate of 15.28% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.68%.

Transmedics Group's revenue in 2025 is $566,354,000.On average, 16 Wall Street analysts forecast TMDX's revenue for 2025 to be $20,944,760,306, with the lowest TMDX revenue forecast at $20,061,012,262, and the highest TMDX revenue forecast at $21,702,063,348. On average, 16 Wall Street analysts forecast TMDX's revenue for 2026 to be $25,236,713,783, with the lowest TMDX revenue forecast at $23,001,371,185, and the highest TMDX revenue forecast at $27,052,395,670.

In 2027, TMDX is forecast to generate $29,683,135,209 in revenue, with the lowest revenue forecast at $26,457,762,415 and the highest revenue forecast at $32,524,388,589.

What is TMDX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: TMDX) forecast ROA is 15.92%, which is higher than the forecast US Medical Devices industry average of 13.34%.

What is TMDX's Price Target?

According to 7 Wall Street analysts that have issued a 1 year TMDX price target, the average TMDX price target is $143.43, with the highest TMDX stock price forecast at $166.00 and the lowest TMDX stock price forecast at $115.00.

On average, Wall Street analysts predict that Transmedics Group's share price could reach $143.43 by Dec 17, 2026. The average Transmedics Group stock price prediction forecasts a potential upside of 12.34% from the current TMDX share price of $127.67.

What is TMDX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: TMDX) Transmedics Group's current Earnings Per Share (EPS) is $2.71. On average, analysts forecast that TMDX's EPS will be $2.66 for 2025, with the lowest EPS forecast at $2.39, and the highest EPS forecast at $3.05. On average, analysts forecast that TMDX's EPS will be $2.95 for 2026, with the lowest EPS forecast at $1.95, and the highest EPS forecast at $3.91. In 2027, TMDX's EPS is forecast to hit $3.64 (min: $2.31, max: $5.38).

What is TMDX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: TMDX) forecast ROE is 42.39%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.